Literature DB >> 11543954

Cellular and molecular aspects of striatal development.

M Jain1, R J Armstrong, R A Barker, A E Rosser.   

Abstract

The striatum is a key component of the basal ganglia and there is considerable evidence that it has an important role in motor, cognitive and limbic functions. However, very little is known about how this forebrain structure develops. This review considers the role of cellular and molecular mechanisms involved in the development of the striatum, and the potential application of this knowledge to the understanding of the pathology and treatment of primary disease of this structure.

Mesh：

Year:  2001        PMID： 11543954     DOI： 10.1016/s0361-9230(01)00555-x

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN： 0361-9230            Impact factor:   4.077


  17 in total

1.  Egr-1 induces DARPP-32 expression in striatal medium spiny neurons via a conserved intragenic element.

Authors:  Serene Keilani; Samira Chandwani; Georgia Dolios; Alexey Bogush; Heike Beck; Antonis K Hatzopoulos; Gadiparthi N Rao; Elizabeth A Thomas; Rong Wang; Michelle E Ehrlich
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

Review 2.  Cell therapy in Huntington's disease.

Authors:  Stephen B Dunnett; Anne E Rosser
Journal:  NeuroRx       Date:  2004-10

3.  Abnormal subcortical activity in congenital mirror movement disorder with RAD51 mutation.

Authors:  Pınar Demirayak; Onur Emre Onat; Aslıhan Örs Gevrekci; Süleyman Gülsüner; Hilmi Uysal; Rengin S Bilgen; Katja Doerschner; Tayfun S Özçelik; Hüseyin Boyacı
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

4.  An embryonic culture system for the investigation of striatal medium spiny neuron dendritic spine development and plasticity.

Authors:  Rachel D Penrod; Saïd Kourrich; Esther Kearney; Mark J Thomas; Lorene M Lanier
Journal:  J Neurosci Methods       Date:  2011-06-13       Impact factor: 2.390

5.  Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges.

Authors:  Camille Nicoleau; Pedro Viegas; Marc Peschanski; Anselme L Perrier
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 6.  Modeling Huntington's disease with induced pluripotent stem cells.

Authors:  Julia A Kaye; Steven Finkbeiner
Journal:  Mol Cell Neurosci       Date:  2013-02-28       Impact factor: 4.314

7.  Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease.

Authors:  Eduardo E Arteaga-Bracho; Maria Gulinello; Michael L Winchester; Nandini Pichamoorthy; Jenna R Petronglo; Alicia D Zambrano; Julio Inocencio; Chirstopher D De Jesus; Joseph O Louie; Solen Gokhan; Mark F Mehler; Aldrin E Molero
Journal:  Neurobiol Dis       Date:  2016-09-10       Impact factor: 5.996

8.  Bioinformatics investigation of therapeutic mechanisms of Xuesaitong capsule treating ischemic cerebrovascular rat model with comparative transcriptome analysis.

Authors:  Jiangquan Liao; Benjun Wei; Hengwen Chen; Yongmei Liu; Jie Wang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

9.  Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats.

Authors:  Laetitia Aubry; Aurore Bugi; Nathalie Lefort; France Rousseau; Marc Peschanski; Anselme L Perrier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-15       Impact factor: 11.205

10.  Dopamine regulates the expression of the glutamate transporter GLT1 but not GLAST in developing striatal astrocytes.

Authors:  Veronica I Brito; Verena E Rozanski; Cordian Beyer; Eva Küppers
Journal:  J Mol Neurosci       Date:  2009-08-15       Impact factor: 3.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.